NorthSea Therapeutics is a clinical-stage biotech company developing first-in-class, oral, structurally engineered lipid therapeutics. The team leverages Structurally Engineered Fatty Acid (SEFA) technology to develop novel and unique therapeutic approaches targeting metabolic, inflammatory, and fibrotic diseases. The SEFA technology has generated pipeline candidates with a broad array of inter-and independent biological effects, improving dyslipidemia, insulin resistance, hepatic inflammation, and fibrosis in diverse models.
Biotechnology, Health Care, Therapeutics
Above €25 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as NorthSea Therapeutics? We’re happy to assist you with our Startup Sourcing service.